Perindopril Erbumine

CAS 107133-36-8 16 current records 6 historicalSmall Molecule

Who holds supplier records for Perindopril Erbumine? 16 organisations hold a current record for Perindopril Erbumine: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 15 of them hold a valid EU Certificate of Suitability (16 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (4), Spain (2), France (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Perindopril Erbumine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/perindopril-erbumine

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 7 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Perindopril Erbumine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Perindopril Erbumine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (16)

Certificates of Suitability on the EDQM register for Perindopril Erbumine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 23 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mestoSI
CEP 2019-235 - Rev 01
Perindopril tert-butylamine, Code 302281
Jul 2026Inspected Jul 2025
Slovenia
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2010-157 - Rev 07
Perindopril tert-butylamine
Jun 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2004-279 - Rev 07
Perindopril tert-butylamine
May 2026—
SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO., LTD. Luoyang TownCN
CEP 2024-556 - Rev 00
Perindopril tert-butylamine
Apr 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2008-009 - Rev 06
Perindopril tert-butylamine
Feb 2026—
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2025-249 - Rev 00
Perindopril tert-butylamine, Crystalline form-α
Jan 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2020-356 - Rev 01
Perindopril tert-butylamine, Process 2, Micronised and Non-micronised
Nov 2025Inspected May 2026
Italy
HETERO DRUGS LIMITED HyderabadIN
CEP 2010-118 - Rev 05
Perindopril tert-butylamine
Mar 2025—
ZHEJIANG CHANGMING PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2023-355 - Rev 01
Perindopril tert-butylamine
Feb 2025—
APOTEX PHARMACHEM INDIA PVT. LTD BangaloreIN
CEP 2019-196 - Rev 02
Perindopril tert-butylamine, PER55LP
Dec 2024—
Laboratorios Servier S.L. ToledoES
CEP 2024-029 - Rev 00
Perindopril tert-butylamine, Laboratorios Servier S.L. (Spain, Toledo)
Jun 2024Inspected Feb 2024
Spain
NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo Hi-Tech DistrictCN
CEP 2022-207 - Rev 00
Perindopril tert-butylamine
Feb 2024—
ROLABO OUTSOURCING, S.L. ZaragozaES
CEP 2004-284 - Rev 02
Perindopril tert-butylamine
Jan 2024Inspected Dec 2023
Spain
AARTI PHARMALABS LIMITED Mulund (W), MumbaiIN
R1-CEP 2013-245 - Rev 02
Perindopril tert-butylamine
Oct 2022—
ORIL INDUSTRIE BolbecFR
R1-CEP 2004-223 - Rev 01
Perindopril tert-butylamine
Jun 2021—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2007-026 - Rev 00
Perindopril tert-butylamine
Sept 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Perindopril Erbumine are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • India · Inactive DMF 22613 · filed Jul 2009
  • India · Inactive DMF 20165 · filed Sept 2007
  • Bachem SA, Succursale de Vionnaz
    Switzerland · Inactive DMF 20788 · filed Aug 2007
  • MYLAN LABORATORIES LTD
    Inactive DMF 18865 · filed Oct 2005
  • India · Inactive DMF 17958 · filed Dec 2004
  • NORAMCO DELAWARE INC
    Inactive DMF 9165 · filed Jun 1991

Overview

Perindopril Erbumine is an angiotensin-converting enzyme (ACE) inhibitor used primarily in the treatment of hypertension and heart failure. It helps to relax blood vessels, improving blood flow and reducing blood pressure.

Chemical identity

IUPAC name
(2S,3aS,7aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxopentan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid;2-methylpropan-2-amine
Canonical SMILES
CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O.CC(C)(C)N
InChIKey
IYNMDWMQHSMDDE-MHXJNQAMSA-N
Synonyms
Aceon API, aceon, amlessa component perindopril erbumine, mcn-a-2833-109, nsc-758929, perindopril t-butylamine, perindopril tert-butylamine, s-9490-3

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin Converting Enzyme Inhibitor
Mechanism of action
Angiotensin-converting Enzyme Inhibitors

Therapeutic areas

Cardiovascular

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Perindopril Erbumine?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Perindopril Erbumine: ALIVUS LIFE SCIENCES LTD (India), APITORIA PHARMA PRIVATE LTD (India), Apotex Pharmachem India Pvt. Ltd. (India), Hetero Drugs Limited (India), MSN PHARMACHEM PRIVATE LTD (India), Zhejiang Changming Pharmaceutical Co.,Ltd (China), Piramal Pharma Limited (India) and AARTI PHARMALABS LIMITED (India), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Perindopril Erbumine Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 17713), APITORIA PHARMA PRIVATE LTD (DMF 19484), Apotex Pharmachem India Pvt. Ltd. (DMF 21393), Hetero Drugs Limited (DMF 19095), MSN PHARMACHEM PRIVATE LTD (DMF 41497), Zhejiang Changming Pharmaceutical Co.,Ltd (DMF 42811) and Piramal Pharma Limited (DMF 28144). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Perindopril Erbumine records mean?

6 organisations have only inactive Type II DMFs for Perindopril Erbumine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Perindopril Erbumine have a European Certificate of Suitability?

Yes. 15 organisations hold a valid CEP for Perindopril Erbumine on the EDQM register, including KRKA TOVARNA ZDRAVIL D.D. NOVO MESTO Novo mesto (SI), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), SHANGHAI PHARMA GROUP CHANGZHOU KONY PHARMACEUTICAL CO., LTD. Luoyang Town (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN) and 10 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Perindopril Erbumine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Perindopril Erbumine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.